Previous 10 | Next 10 |
SOUTH ORANGE, N.J., June 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH ), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announc...
Executives to Present Business Overviews SOUTH ORANGE, NJ, May 11, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH) announced today that, due to the public health concerns associated with the ongoing coronavirus outbreak and to support the health and we...
Nephros (NASDAQ: NEPH ): Q1 GAAP EPS of -$0.13 misses by $0.04 . More news on: Nephros, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
SOUTH ORANGE, NJ, April 29, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that i...
Nephros (NASDAQ: NEPH ) expects Q1 net revenues to be $2.6M (+45% Y/Y). More news on: Nephros, Inc., Consumer stocks news, Read more ...
Anticipates $2.6 Million Net Revenues, Approximately 45% Growth Over 2019 SOUTH ORANGE, NJ, April 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros , Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and patho...
Medical Device Veteran Hired to Drive FDA Clearance and Market Launch SOUTH ORANGE, NJ, March 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Specialty Renal Products, Inc. (SRP), a subsidiary of Nephros, Inc. (Nasdaq:NEPH), a medical device company that develops and sells...
SOUTH ORANGE, NJ, March 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc.(Nasdaq: NEPH), a commercial stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announc...
Nephros (NASDAQ: NEPH ): FY GAAP EPS of -$0.45 beats by $0.10 . More news on: Nephros, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Fourth Quarter Net Revenue up 96%; Annual Net Revenue up 82% Establishes 2020 Revenue Guidance at $14.5 to $15.5 Million SOUTH ORANGE, N.J., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq:NEPH), a commercial stage company that develops and sells high performance water purific...
News, Short Squeeze, Breakout and More Instantly...
First-Quarter Net Revenue of $3.5 Million; Technology Advancements and Microplastics Capabilities on the Horizon SOUTH ORANGE, NJ - ( NewMediaWire ) - May 09, 2024 - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and co...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
SOUTH ORANGE, NJ - ( NewMediaWire ) - May 02, 2024 - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions for both healthcare and commercial markets, today announced that it will file its first quarter financial results on Thursday, May 09, 2024 after ...